BAM
AGN

Berkshire Asset Management’s Allergan plc AGN Stock Holding History

Berkshire Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,909
Closed -$1.4M – 202
2020
Q1 		$1.4M Buy
7,909
+4,282
+118% +$806K 0.15% 81
2019
Q4 		$693K Sell
3,627
-345
-9% -$62.2K 0.06% 111
2019
Q3 		$668K Buy
3,972
+1,078
+37% +$176K 0.06% 128
2019
Q2 		$485K Buy
2,894
+356
+14% +$49.3K 0.04% 137
2019
Q1 		$372K Hold
2,538
– – 0.03% 166
2018
Q4 		$339K Sell
2,538
-690
-21% -$113K 0.03% 167
2018
Q3 		$615K Sell
3,228
-11
-0.3% -$2.02K 0.05% 135
2018
Q2 		$540K Buy
3,239
+131
+4% +$21K 0.05% 133
2018
Q1 		$523K Buy
3,108
+750
+32% +$126K 0.05% 133
2017
Q4 		$386K Buy
2,358
+506
+27% +$90.8K 0.04% 159
2017
Q3 		$380K Hold
1,852
– – 0.04% 144
2017
Q2 		$450K Sell
1,852
-64
-3% -$15K 0.05% 130
2017
Q1 		$458K Buy
1,916
+56
+3% +$13K 0.05% 132
2016
Q4 		$391K Sell
1,860
-67
-3% -$13.9K 0.05% 133
2016
Q3 		$444K Sell
1,927
-654
-25% -$160K 0.06% 125
2016
Q2 		$596K Buy
2,581
+689
+36% +$159K 0.09% 109
2016
Q1 		$507K Hold
1,892
– – 0.08% 102
2015
Q4 		$591K Buy
1,892
+33
+2% +$9.82K 0.1% 98
2015
Q3 		$505K Buy
+1,859
New +$571K 0.09% 98
2015
Q2 		– Sell
-2,127
Closed -$633K – 168
2015
Q1 		$633K Sell
2,127
-74
-3% -$21.1K 0.11% 97
2014
Q4 		$567K Buy
2,201
+4
+0.2% +$1K 0.1% 100
2014
Q3 		$530K Buy
+2,197
New +$492K 0.1% 103

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Berkshire Asset Management's AGN Position: Q2 2020 in Review

Berkshire Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,909 shares — an estimated $1.4M sold.

Berkshire Asset Management first reported a position in AGN in Q3 2014 and held it in 22 quarters. The position peaked at $1.4M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Berkshire Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Berkshire Asset Management sold 7,909 Allergan plc shares in Q2 2020, an estimated $1.4M.
  • Berkshire Asset Management first reported a position in Allergan plc in Q3 2014 and held it in 22 quarters.
  • Berkshire Asset Management's Allergan plc position peaked at $1.4M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Berkshire Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.